Antipsychotic medications are prescribed by physicians for a wide variety of psychiatric disorders. Older antipsychotics include drugs such as chlorpromazine and haloperidol. There are an increasing ...

Antipsychotic medication is used in schizophrenia, severe depression, elation (in bipolar disorder), and other conditions. These medications offer many benefits provided they are used with care and ...

Antipsychotic medications are overprescribed in long-term care. They are powerful medications with a host of potential adverse reactions, including death. Government agencies and surveyors follow the ...

Patients with severe mental illnesses, such as schizophrenia and bipolar disorder, often require long-term use of antipsychotic medications. Some of these drugs, however, can pose potential risks, ...

A study analyzed data from nearly 500,000 Canadian patients who lived in nursing homes across Canada between 2000 and 2022. It found that residents who were given antipsychotic medications showed a ...

Schizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as second-generation or "atypical" antipsychotics ...

Parkinson’s patients taking antipsychotic medications have a significant increased risk of death, according to a new study published in JAMA Neurology and covered by News Medical. For the study, ...

Antipsychotic use among Medicaid-insured children from low- or very-low-income families skyrocketed in just under a decade, new research shows. Investigators from the University of Maryland in ...

Most people with schizophrenia are prescribed antipsychotic medications that improve many of these symptoms. Researchers hypothesized that these medications may also reduce the risk of a motor vehicle ...

In drivers with schizophrenia, better adherence to antipsychotic medication is associated with a lower risk for motor vehicle crashes, according to new research. In a case-crossover study, perfect ...

A new study conducted by researchers at the University of Waterloo analyzed data from nearly 500,000 Canadian patients who lived in nursing homes across Canada between 2000 and 2022. It found that ...